Cargando…
Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
INTRODUCTION: Anti-estrogen therapy has been shown to reduce mammographic breast density (MD). We hypothesized that a short-term change in breast density may be a surrogate biomarker predicting response to adjuvant endocrine therapy (ET) in breast cancer. METHODS: We analyzed data for 1,065 estrogen...
Autores principales: | Kim, Jisun, Han, Wonshik, Moon, Hyeong-Gon, Ahn, Soo Kyung, Shin, Hee-Chul, You, Jee-Man, Han, Sae-Won, Im, Seock-Ah, Kim, Tae-You, Koo, Hye Ryoung, Chang, Jung Min, Cho, Nariya, Moon, Woo Kyung, Noh, Dong-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680951/ https://www.ncbi.nlm.nih.gov/pubmed/22770227 http://dx.doi.org/10.1186/bcr3221 |
Ejemplares similares
-
Correction: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
por: Kim, Jisun, et al.
Publicado: (2012) -
Low Rates of Additional Cancer Detection by Magnetic Resonance Imaging in Newly Diagnosed Breast Cancer Patients Who Undergo Preoperative Mammography and Ultrasonography
por: Kim, Jisun, et al.
Publicado: (2014) -
Nomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy
por: Kim, Min Kyoon, et al.
Publicado: (2015) -
Endocrine Treatment-Related Symptoms and Patient Outcomes in Breast Cancer: A Meta-Analysis
por: Yoo, Tae-Kyung, et al.
Publicado: (2018) -
Reliability of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Han, Ahram, et al.
Publicado: (2013)